Onesano S.A. Logo

Onesano S.A.

Develops patented nutritional products for humans, animals, and agriculture.

SKT | WAR

Overview

Corporate Details

ISIN(s):
PLSKTAN00010 (+1 more)
LEI:
259400O0ENJE93KANI38
Country:
Poland
Address:
CHORZÓW DYREKCYJNA 6, 41-506 CHORZÓW
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Onesano S.A. is a Polish biotechnology company specializing in the research, development, and production of innovative products for the full nutritional cycle. The company's portfolio includes natural dietary supplements for humans, animal nutrition products, and solutions for agriculture. Leveraging its own R&D laboratories and two production plants, Onesano develops proprietary, patented formulas and offers private label manufacturing services. The company, formerly known as Skotan S.A., operates an extensive distribution network and is committed to creating solutions that support human and planetary health through science-backed products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 21:12
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.1 KB
2025-09-04 18:30
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 1.2 KB
2025-09-03 20:48
Legal Proceedings Report
Aktualizacja informacji dotyczących zwrotu środków pochodzących z umowy o dofin…
Polish 2.7 KB
2025-08-14 17:20
Interim Report
onesano_SA_raport_polroczny_IH2025
Polish 2.3 MB
2025-08-14 17:20
Audit Report / Information
RAPORT_przegląd_IH2025
Polish 241.4 KB
2025-08-11 21:43
Registration Form
Statut_onesano_SA_po_rejestracji_w_dn.11.08.2025
Polish 515.2 KB
2025-08-11 21:43
Governance Information
Rejestracja zmian Statutu Spółki - Content (PL)
Polish 6.7 KB
2025-06-30 18:17
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy dysponujących co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 539 bytes
2025-06-30 18:07
Board/Management Information
Życiorys-członka-RN-onesano-JBlaszczak
Polish 278.7 KB
2025-06-30 18:07
Board/Management Information
Powołanie osoby nadzorującej - Content (PL)
Polish 2.2 KB
2025-06-30 17:55
Registration Form
onesano_Zalacznik_do_uchwaly_nr_18_ZWZ_30.06.2025
Polish 515.1 KB
2025-06-30 17:55
Remuneration Information
onesano_Sprawozdanie_Rady_Nadzorczej_o_wynagrodzeniach_za_2024r.
Polish 1.2 MB
2025-06-30 17:55
Board/Management Information
onesano_Sprawozdanie_RN_z_dzialalnosci_w_2024r.
Polish 1.3 MB
2025-06-30 17:55
Post-Annual General Meeting Information
onesano_Uchwaly_ZWZ_30.06.2025
Polish 528.0 KB
2025-06-30 17:55
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie onesano S.A. w dniu 30 czerw…
Polish 911 bytes

Automate Your Workflow. Get a real-time feed of all Onesano S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Onesano S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.